{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:29:41Z","timestamp":1762507781820,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00432-019-02956-6","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T16:02:41Z","timestamp":1561132961000},"page":"2131-2140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette\u2013Gu\u00e9rin immunotherapy"],"prefix":"10.1007","volume":"145","author":[{"given":"Sung Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalsan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumsik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2705-0481","authenticated-orcid":false,"given":"Jun Hyuk","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"2956_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/00365590410028692","volume":"38","author":"P Andius","year":"2004","unstructured":"Andius P, Damm O, Holmang S (2004) Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette\u2013Guerin. Scand J Urol Nephrol 38:285\u2013290","journal-title":"Scand J Urol Nephrol"},{"key":"2956_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, Bohle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461. \n                              https:\/\/doi.org\/10.1016\/j.eururo.2016.05.041","journal-title":"Eur Urol"},{"key":"2956_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.urology.2010.01.032","volume":"76","author":"D Cao","year":"2010","unstructured":"Cao D, Vollmer RT, Luly J, Jain S, Roytman TM, Ferris CW, Hudson MA (2010) Comparison of 2004 and 1973 world health organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 76:593\u2013599. \n                              https:\/\/doi.org\/10.1016\/j.urology.2010.01.032","journal-title":"Urology"},{"key":"2956_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.juro.2010.03.134","volume":"184","author":"DC Chade","year":"2010","unstructured":"Chade DC, Shariat SF, Adamy A, Bochner BH, Donat SM, Herr HW, Dalbagni G (2010) Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol 184:464\u2013469. \n                              https:\/\/doi.org\/10.1016\/j.juro.2010.03.134","journal-title":"J Urol"},{"key":"2956_CR5","doi-asserted-by":"publisher","first-page":"14016","DOI":"10.1073\/pnas.0906549106","volume":"106","author":"KS Chan","year":"2009","unstructured":"Chan KS, Espinosa I, Chao M et al (2009) Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA 106:14016\u201314021. \n                              https:\/\/doi.org\/10.1073\/pnas.0906549106","journal-title":"Proc Natl Acad Sci USA"},{"key":"2956_CR6","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","volume":"85","author":"L Cheng","year":"1999","unstructured":"Cheng L, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Bostwick DG (1999) Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85:2469\u20132474","journal-title":"Cancer"},{"key":"2956_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.urolonc.2007.12.011","volume":"27","author":"ON Gofrit","year":"2009","unstructured":"Gofrit ON, Pode D, Pizov G, Zorn KC, Katz R, Duvdevani M, Shapiro A (2009) The natural history of bladder carcinoma in situ after initial response to bacillus Calmette\u2013Guerin immunotherapy. Urol Oncol 27:258\u2013262. \n                              https:\/\/doi.org\/10.1016\/j.urolonc.2007.12.011","journal-title":"Urol Oncol"},{"key":"2956_CR8","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/S0022-5347(05)64994-4","volume":"167","author":"TR Griffiths","year":"2002","unstructured":"Griffiths TR, Charlton M, Neal DE, Powell PH (2002) Treatment of carcinoma in situ with intravesical bacillus Calmette\u2013Guerin without maintenance. J Urol 167:2408\u20132412","journal-title":"J Urol"},{"key":"2956_CR9","first-page":"499","volume":"19","author":"DL Lamm","year":"1992","unstructured":"Lamm DL (1992) Carcinoma in situ. Urol Clin North Am 19:499\u2013508","journal-title":"Urol Clin North Am"},{"key":"2956_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.juro.2013.07.102","volume":"191","author":"D Lamm","year":"2014","unstructured":"Lamm D, Persad R, Brausi M, Buckley R, Witjes JA, Palou J, Bohle A, Kamat AM, Colombel M, Soloway M (2014) Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. J Urol 191:20\u201327. \n                              https:\/\/doi.org\/10.1016\/j.juro.2013.07.102","journal-title":"J Urol"},{"key":"2956_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.urolonc.2010.04.008","volume":"28","author":"DJ McConkey","year":"2010","unstructured":"McConkey DJ, Lee S, Choi W, Tran M, Majewski T, Lee S, Siefker-Radtke A, Dinney C, Czerniak B (2010) Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol Oncol 28:429\u2013440. \n                              https:\/\/doi.org\/10.1016\/j.urolonc.2010.04.008","journal-title":"Urol Oncol"},{"key":"2956_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette\u2013Guerin in the treatment of superficial bladder tumors. J Urol 116:180\u2013183","journal-title":"J Urol"},{"key":"2956_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.urology.2005.08.066","volume":"66","author":"AM Nieder","year":"2005","unstructured":"Nieder AM, Brausi M, Lamm D, O\u2019Donnell M, Tomita K, Woo H, Jewett MA (2005) Management of stage T1 tumors of the bladder: international consensus panel. Urology 66:108\u2013125. \n                              https:\/\/doi.org\/10.1016\/j.urology.2005.08.066","journal-title":"Urology"},{"key":"2956_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/1097-0142(19940701)74:1<115::AID-CNCR2820740120>3.0.CO;2-R","volume":"74","author":"RE Orozco","year":"1994","unstructured":"Orozco RE, Martin AA, Murphy WM (1994) Carcinoma in situ of the urinary bladder: clues to host involvement in human carcinogenesis. Cancer 74:115\u2013122","journal-title":"Cancer"},{"key":"2956_CR15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/bju.13345","volume":"117","author":"D Ramirez","year":"2016","unstructured":"Ramirez D, Gupta A, Canter D et al (2016) Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int 117:783\u2013786. \n                              https:\/\/doi.org\/10.1111\/bju.13345","journal-title":"BJU Int"},{"key":"2956_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1308\/003588403322520717","volume":"85","author":"R Singh","year":"2003","unstructured":"Singh R, Saleemi A, Walsh K, Popert R, O\u2019Brien T (2003) Near misses in bladder cancer: an airline safety approach to urology. Ann R Coll Surg Engl 85:378\u2013381. \n                              https:\/\/doi.org\/10.1308\/003588403322520717","journal-title":"Ann R Coll Surg Engl"},{"key":"2956_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013477. \n                              https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031\n                              \n                           \n                           (discussion 475\u2013467)","journal-title":"Eur Urol"},{"key":"2956_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1442-2042.2008.02012.x","volume":"15","author":"A Takenaka","year":"2008","unstructured":"Takenaka A, Yamada Y, Miyake H, Hara I, Fujisawa M (2008) Clinical outcomes of bacillus Calmette\u2013Guerin instillation therapy for carcinoma in situ of urinary bladder. Int J Urol 15:309\u2013313. \n                              https:\/\/doi.org\/10.1111\/j.1442-2042.2008.02012.x","journal-title":"Int J Urol"},{"key":"2956_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0090-4295(99)80047-8","volume":"45","author":"RJ van Gils-Gielen","year":"1995","unstructured":"van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO (1995) Risk factors in carcinoma in situ of the urinary bladder: dutch South East cooperative urological group. Urology 45:581\u2013586","journal-title":"Urology"},{"key":"2956_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2003.09.013","volume":"45","author":"JA Witjes","year":"2004","unstructured":"Witjes JA (2004) Bladder carcinoma in situ in 2003: state of the art. Eur Urol 45:142\u2013146. \n                              https:\/\/doi.org\/10.1016\/j.eururo.2003.09.013","journal-title":"Eur Urol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02956-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T23:11:37Z","timestamp":1592608297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02956-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2956"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02956-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"type":"print","value":"0171-5216"},{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"22 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data cannot be made available because of restrictions imposed by the Asan Medical Center Institutional Review Board (). In case of further questions, the homepage of the IRB is \u201c\u201d and the contact number for the person in charge of document access is \u201cTel: +82-2-3010-7165.\u201d","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}